Skip to main content

View full-text article in PMC

. 2018 Jan 22;13(1):e0191262. doi: 10.1371/journal.pone.0191262

Table 2. Changes in biomedical outcomes from baseline to 12 months.

The ST2EP trial in Mali. Data are mean (CI 95%).

	Intervention group (n = 70)	Control group (n = 70)	p-value
Body Mass Index, kg/m²	-1.65 (-2.25; -1.06)	0.05 (-0.71; 0.81)	0.0005
Waist circumference, cm	-3.34 (-5.56;-1.13)	2.65 (0.20;5.09)	0.0003
Systolic BP, mm Hg	-6.46 (-11.63;-1.28)	3.57 (-0.17;7.31)	0.003
Diastolic BP, mm Hg	0.40 (-2.27;3.07)	2.00 (-0.77;4.77)	0.36
HbA1c, %	-1.05 (-1.54; -0.56)	-0.15 (-0.56; 0.26)	0.006
Knowledge score	1.06 (0.70;1.42)	0.61 (0.23;0.99)	0.17